A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum]

Klapproth AP, Shevtsov M, Stangl S, Li WB, Multhoff G. Int J Nanomedicine. 2020;15:4677–4689. The authors have advised the author and affiliation list on page 4677 is incorrect. The correct author list and affiliationsare as follows. Alexander P Klapproth1,2,*Max...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Klapproth AP, Shevtsov M, Stangl S, Li WB, Multhoff G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	mathematical modeling spions superparamagnetic iron oxide nanoparticles pharmacokinetic model glioblastoma biodistribution Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/53b9129771da4931875d20be9cdd2c4f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:53b9129771da4931875d20be9cdd2c4f
record_format	dspace
spelling	oai:doaj.org-article:53b9129771da4931875d20be9cdd2c4f2021-12-02T03:57:59ZA New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum]1178-2013https://doaj.org/article/53b9129771da4931875d20be9cdd2c4f2020-08-01T00:00:00Zhttps://www.dovepress.com/corrigendun-a-new-pharmacokinetic-model-describing-the-biodistribution-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Klapproth AP, Shevtsov M, Stangl S, Li WB, Multhoff G. Int J Nanomedicine. 2020;15:4677–4689. The authors have advised the author and affiliation list on page 4677 is incorrect. The correct author list and affiliationsare as follows. Alexander P Klapproth1,2,Maxim Shevtsov1,3–7,Thomas J Carter8Stefan Stangl1Kerry Chester8Wei Bo Li2Gabriele Multhoff1 1Center for Translational Cancer Research Technische Universität München (TranslaTUM), Klinikum Rechts Der Isar, Munich, Germany; 2Institute of Radiation Medicine, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Munich, Germany; 3Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia; 4Department of Biotechnology, First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia; 5Almazov National Medical Research Centre, Russian Polenov Neurosurgical Institute, St. Petersburg, Russia; 6National Center for Neurosurgery, Nur-Sultan, Kazakhstan; 7Department of Biomedical Cell Technologies, Far Eastern Federal University, Vladivostok,Russia; 8UCL Cancer Institute, University College London, London, UK *These authors contributed equally to this work Page 4682, Intravenously Injected SPIONs section, the text “To further validate the model, two datasets from mice with intravenously injected SPIONs were analyzed” should read “To further validate the model, two previously published supplementary datasets from mice with intravenously injected SPIONs were analyzed”. Read the original article  Klapproth APShevtsov MStangl SLi WBMulthoff GDove Medical Pressarticlemathematical modelingspionssuperparamagnetic iron oxide nanoparticlespharmacokinetic modelglioblastomabiodistributionMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 6067-6068 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	mathematical modeling spions superparamagnetic iron oxide nanoparticles pharmacokinetic model glioblastoma biodistribution Medicine (General) R5-920
spellingShingle	mathematical modeling spions superparamagnetic iron oxide nanoparticles pharmacokinetic model glioblastoma biodistribution Medicine (General) R5-920 Klapproth AP Shevtsov M Stangl S Li WB Multhoff G A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum]
description	Klapproth AP, Shevtsov M, Stangl S, Li WB, Multhoff G. Int J Nanomedicine. 2020;15:4677–4689. The authors have advised the author and affiliation list on page 4677 is incorrect. The correct author list and affiliationsare as follows. Alexander P Klapproth1,2,Maxim Shevtsov1,3–7,Thomas J Carter8Stefan Stangl1Kerry Chester8Wei Bo Li2Gabriele Multhoff1 1Center for Translational Cancer Research Technische Universität München (TranslaTUM), Klinikum Rechts Der Isar, Munich, Germany; 2Institute of Radiation Medicine, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Munich, Germany; 3Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia; 4Department of Biotechnology, First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia; 5Almazov National Medical Research Centre, Russian Polenov Neurosurgical Institute, St. Petersburg, Russia; 6National Center for Neurosurgery, Nur-Sultan, Kazakhstan; 7Department of Biomedical Cell Technologies, Far Eastern Federal University, Vladivostok,Russia; 8UCL Cancer Institute, University College London, London, UK *These authors contributed equally to this work Page 4682, Intravenously Injected SPIONs section, the text “To further validate the model, two datasets from mice with intravenously injected SPIONs were analyzed” should read “To further validate the model, two previously published supplementary datasets from mice with intravenously injected SPIONs were analyzed”. Read the original article
format	article
author	Klapproth AP Shevtsov M Stangl S Li WB Multhoff G
author_facet	Klapproth AP Shevtsov M Stangl S Li WB Multhoff G
author_sort	Klapproth AP
title	A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum]
title_short	A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum]
title_full	A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum]
title_fullStr	A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum]
title_full_unstemmed	A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum]
title_sort	new pharmacokinetic model describing the biodistribution of intravenously and intratumorally administered superparamagnetic iron oxide nanoparticles (spions) in a gl261 xenograft glioblastoma model [corrigendum]
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/53b9129771da4931875d20be9cdd2c4f
work_keys_str_mv	AT klapprothap anewpharmacokineticmodeldescribingthebiodistributionofintravenouslyandintratumorallyadministeredsuperparamagneticironoxidenanoparticlesspionsinagl261xenograftglioblastomamodelcorrigendum AT shevtsovm anewpharmacokineticmodeldescribingthebiodistributionofintravenouslyandintratumorallyadministeredsuperparamagneticironoxidenanoparticlesspionsinagl261xenograftglioblastomamodelcorrigendum AT stangls anewpharmacokineticmodeldescribingthebiodistributionofintravenouslyandintratumorallyadministeredsuperparamagneticironoxidenanoparticlesspionsinagl261xenograftglioblastomamodelcorrigendum AT liwb anewpharmacokineticmodeldescribingthebiodistributionofintravenouslyandintratumorallyadministeredsuperparamagneticironoxidenanoparticlesspionsinagl261xenograftglioblastomamodelcorrigendum AT multhoffg anewpharmacokineticmodeldescribingthebiodistributionofintravenouslyandintratumorallyadministeredsuperparamagneticironoxidenanoparticlesspionsinagl261xenograftglioblastomamodelcorrigendum AT klapprothap newpharmacokineticmodeldescribingthebiodistributionofintravenouslyandintratumorallyadministeredsuperparamagneticironoxidenanoparticlesspionsinagl261xenograftglioblastomamodelcorrigendum AT shevtsovm newpharmacokineticmodeldescribingthebiodistributionofintravenouslyandintratumorallyadministeredsuperparamagneticironoxidenanoparticlesspionsinagl261xenograftglioblastomamodelcorrigendum AT stangls newpharmacokineticmodeldescribingthebiodistributionofintravenouslyandintratumorallyadministeredsuperparamagneticironoxidenanoparticlesspionsinagl261xenograftglioblastomamodelcorrigendum AT liwb newpharmacokineticmodeldescribingthebiodistributionofintravenouslyandintratumorallyadministeredsuperparamagneticironoxidenanoparticlesspionsinagl261xenograftglioblastomamodelcorrigendum AT multhoffg newpharmacokineticmodeldescribingthebiodistributionofintravenouslyandintratumorallyadministeredsuperparamagneticironoxidenanoparticlesspionsinagl261xenograftglioblastomamodelcorrigendum
_version_	1718401485933379584

A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum]

Ejemplares similares